Navidea Biopharmaceuticals Inc organizacji Cel na 1 rok

Jaka jest wartość Cel na 1 rok organizacji Navidea Biopharmaceuticals Inc?

Wartość Cel na 1 rok organizacji Navidea Biopharmaceuticals Inc to $8 +749,900.00%

Jaka jest definicja Cel na 1 rok?

Cel na 1 rok to przewidywana cena akcji za rok od dnia dzisiejszego.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

Cel na 1 rok firm w Health Care sektor na NYSEMKT w porównaniu do Navidea Biopharmaceuticals Inc

Czym się zajmuję organizacja Navidea Biopharmaceuticals Inc?

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Firmy z cel na 1 rok podobne do Navidea Biopharmaceuticals Inc